Lipid Disorders
News
FDA accepts supplemental New Drug Application to expand lorcaserin label
The application is based on the CAMELLIA-TIMI-61 trial results.
From the Journals
AHA: Consider obesity as CVD risk factor in children
The updated AHA scientific statement is aimed at pediatric cardiologists and physicians who care for at-risk pediatric patients.
Cardiocast
Who is least adherent to statins, and more
Also on Cardiocast: Covert strokes after noncardiac surgery affect cognition later.
From the Journals
Hormone therapy in transgender individuals may up risk of CV events
“It may be helpful to reduce risk factors by stopping smoking, exercising, eating a healthy diet, and losing weight, if needed before starting...
From the Journals
Statin adherence lower in women, minorities
Women and minorities are significantly less adherent to statin medication, which is linked with an increased risk of hospitalization and death.
Conference Coverage
Consider adopting the MESA 10-year CHD risk calculator
SNOWMASS, COLO. – “I use the MESA. I like it because it gives me options I don’t have with the PCE.” –Robert A. Vogel, MD
From the Journals
Biologics curb coronary artery plaques in severe psoriasis
Treating psoriasis with biologics improves coronary plaque profiles, suggesting an impact on inflammation and opportunity to reduce cardiovascular...
Conference Coverage
SGLT2 inhibitors morph into HF drugs
“
Cardiocast
‘Simple’ way to cut PAD risk, misguided ED visits for atrial fib, and more
Listen in to the latest Cardiocast for the week’s top news.
From the Journals
Statins cut vascular events in elderly patients
Analysis challenges current practice of discontinuation after age 75 years.
From the Journals
Elevated CAC not linked to increased death risk in physically active men